go back

Idecabtagene Vicleucel (Abecma), up to 460 Million Cells

New Jersey rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $13,804 · 10th to 90th $135 to $30,200Professionalmedian $426,580 · 10th to 90th $426,580 to $426,580
$100$1K$10K$100Kfacility $13,804professional $426,580

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$134.90
Median
$13,803.84
Typical High
$30,199.52
Horizon BCBS
Setting
Professional
Modifier
Global
Typical Low
$426,579.52
Median
$426,579.52
Typical High
$426,579.52
United
Setting
Professional
Modifier
Global
Typical Low
$549,540.87
Median
$549,540.87
Typical High
$549,540.87